Latest news with #GiantExim
Mint
2 days ago
- Business
- Mint
Small-cap stock below ₹20 hits upper circuit after THIS export order update
Small-cap stock below ₹ 20: Welcure Drugs and Pharmaceuticals share price surged as much as 5 per cent to hit the upper price band of ₹ 14.28 in Tuesday's trading session after securing two export sourcing orders worth around ₹ 85.6 crore ( ₹ 42.8 crore each). The small-cap stock has gained over 26.71 per cent in over a month and 29 per cent in six months despite a volatile Indian stock market. Welcure Drugs & Pharmaceuticals Limited, a company involved in the production and marketing of a diverse range of pharmaceutical products, has announced the signing of two major export-sourcing deals worth approximately ₹ 85.6 crore with international partners Giant Exim and Ravina International. Here's what the company said in the exchange filing: The orders will contribute fee-based revenue, with no inventory or logistics risk to the company. Commission income will be recognised on the dispatch of each lot and is expected to enhance margins in the current quarter. The company is in advanced discussions with additional international buyers for similar export sourcing mandates and expects to conclude further orders worth ₹ 200 million or more within the ongoing quarter, subject to customary commercial formalities. The company remains focused on expanding its fee-based export portfolio while maintaining its debt-free capital structure. Welcure Drugs and Pharmaceuticals reported a standalone net profit of ₹ 2.54 crore for the quarter ended March 2025. This is a significant turnaround from a net loss of ₹ 0.02 crore in the previous quarter. The company also saw a substantial increase in sales, with the figure at ₹ 21.21 crore in the March 2025 quarter, compared to no sales in the corresponding quarter of the previous year. For the full year, the company reported a net profit of ₹ 2.17 crore, against a net loss of ₹ 0.17 crore in the previous year. Welcure Drugs & Pharmaceuticals, established in 1992, is an Indian pharmaceutical company based in New Delhi. It specialises in producing and marketing a range of pharmaceutical formulations, such as tablets, capsules, dry syrups, and other medicinal products across various drug categories.
Time of India
2 days ago
- Business
- Time of India
Welcure Drugs & Pharma secures export orders worth Rs 86 crore
Welcure Drugs & Pharmaceuticals on Tuesday said it has bagged two export orders worth Rs 85.6 crore from Giant Exim and Ravina International . On June 30, the company received a Rs 42.8 crore order each from Giant Exim and Ravina International for procurement and consolidation of mycorrhizal inoculant (EXW), a statement said. "The orders will contribute fee-based revenue , with no inventory or logistics risk to the company," it added. The company is in advanced discussions with additional international buyers for similar export sourcing mandates and expects to conclude further orders worth Rs 20 crore or more within the ongoing quarter, Welcure said. It recently secured a Rs 517 crore global sourcing mandate from Thailand-based Fortune Sagar Impex Company . Live Events "The company remains focused on expanding its fee-based export portfolio while maintaining its debt-free capital structure ," Welcure stated.
